Erythrasma cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
m Changes made per Mahshid's request |
Category |
||
Line 17: | Line 17: | ||
{{WS}} | {{WS}} | ||
{{WH}} | {{WH}}[[Category:Emergency medicine]] | ||
[[Category:Disease]] | |||
[[Category:Primary care]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Dermatology]] |
Revision as of 01:34, 21 September 2017
Erythrasma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Erythrasma cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Erythrasma cost-effectiveness of therapy |
Risk calculators and risk factors for Erythrasma cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.